Abstract: A light emitting display device includes a first display area; and a second display area disposed adjacent to the first display area, wherein the second display area includes a pixel driving part, a main light-emitting element directly connected to the pixel driving part, and an additional light-emitting element connected to the main light-emitting element, the additional light-emitting element overlaps a peripheral driving part in a plan view, the peripheral driving part generates a signal provided to the pixel driving part, the main light-emitting element and the additional light-emitting element each include a first electrode, an emission layer, and a second electrode, the pixel driving part is electrically connected to the second electrode of the main light-emitting element and the second electrode of the additional light-emitting element, and the second electrode of the additional light-emitting element and the second electrode of the main light-emitting element are separated by a separator.

Abstract: A light emitting display device includes a first display area; and a second display area disposed on an external side of the first display area, wherein the second display area includes a pixel driver, a main light emitting diode electrically connected to the pixel driver, and an additional light emitting diode electrically connected to the main light emitting diode, the additional light emitting diode overlaps a peripheral driver that generates signals provided to the pixel driver, the main light emitting diode and the additional light emitting diode each include a first electrode, an emission layer, and a second electrode, and the second electrode of the main light emitting diode is electrically connected to the first electrode of the additional light emitting diode.

Abstract: An embodiment solid electrolyte includes a first compound and a second compound. The first compound is represented by a first chemical formula Li7-aPS6-a(X11-bX2b)a, wherein X1 and X2 are the same or different and each represents F, Cl, Br, or I, and wherein 0<a?2 and 0<b<1, and the second compound is represented by a second chemical formula Li7-cP1-2dMdS6-c-3d(X11-eX2e)c, wherein X1 and X2 are the same or different and each represents F, Cl, Br, or I, wherein M represents Ge, Si, Sn, or any combination thereof, and wherein 0<c?2, 0<d<0.5, and 0<e<1.

Abstract: The inventive concept provides a substrate treating apparatus. The substrate treating apparatus includes a chamber having a treating space therein; a supply line having a first open/close valve installed thereon and configured to supply a treating fluid to the treating space; a heater installed on the supply line and configured to heat the treating fluid; an exhaust line having a second open/close valve installed thereon and configured to exhaust the treating space; and, a controller configured to control the first open/close value and the second open/close valve such that the treating fluid heated is supplied to and exhausted from the treating space before a treating process is performed on a substrate in the treating space.

Abstract: Disclosed are a display device and a method for manufacturing the same. The display device according to an embodiment includes a transistor that is disposed on a substrate, a first electrode that is disposed on the substrate, a pixel defining layer that is disposed on the first electrode, a separator pattern that is disposed on the pixel defining layer, auxiliary wiring that is disposed between the pixel defining layer and the separator pattern, a second electrode that is disposed on the first electrode, the pixel defining layer, and the separator pattern, connection wiring that connects the transistor to the second electrode, and an intermediate layer that is disposed between the first electrode and the second electrode. A portion of the second electrode disposed on the separator pattern and a portion of the second electrode disposed around the separator pattern are separated from each other.

Abstract: A display device includes: a substrate; a transistor disposed on the substrate; a first electrode disposed on the substrate; a pixel definition layer disposed on the first electrode; a separator pattern layer disposed on the pixel definition layer; a second electrode disposed on the first electrode, the pixel definition layer, and the separator pattern layer; a connection layer connected between the transistor and the second electrode; an emission layer disposed between the first electrode and the second electrode; a conductive pattern layer; and a capping member covering a side end portion of the conductive pattern layer, wherein the conductive pattern layer and the connection layer are disposed on a same layer, and a part of the second electrode disposed on the separator pattern layer and a part of the second electrode disposed around the separator pattern layer are separated from each other.

Abstract: The present invention relates to a novel pyrimidine derivative and a use thereof. The pyrimidine derivative has excellent MLK3 inhibitory activity and LRRK2 inhibitory activity and thus can be utilized in a pharmaceutical composition for preventing or treating cancers, virus infectious diseases, Parkinson's disease, nonalcoholic fatty liver disease, and tuberculosis.

Abstract: A display device according to an embodiment includes a plurality of pixel blocks including a plurality of pixels connected to a plurality of scan lines and a plurality of data lines, respectively, and at least one active circuit; and a data driver supplying a data voltage to the plurality of data lines in a light emitting mode and supplying a neural network input signal to the plurality of data lines in an artificial neural network mode. In the artificial neural network mode, a scan signal is supplied to a scan line connected to at least one pixel block among the plurality of pixel blocks, and the neural network input signal is supplied to a data line connected to the at least one pixel block.

Abstract: The present invention relates to a novel indazole derivative, and a use thereof, wherein the indazole derivative has excellent TRIB2 or YAP inhibitory activity, and can be effectively used as a pharmaceutical composition for preventing or treating cancer, narcolepsy, and fasciitis.

Abstract: A display device according to an embodiment includes a plurality of pixel blocks including a plurality of pixels connected to a plurality of scan lines and a plurality of data lines, respectively, and at least one active circuit; and a data driver supplying a data voltage to the plurality of data lines in a light emitting mode and supplying a neural network input signal to the plurality of data lines in an artificial neural network mode. In the artificial neural network mode, a scan signal is supplied to a scan line connected to at least one pixel block among the plurality of pixel blocks, and the neural network input signal is supplied to a data line connected to the at least one pixel block.

Abstract: A thermoplastic resin composition of the present invention comprises: approximately 100 parts by weight of a polycarbonate resin; approximately 0.01-2 parts by weight of a modified aromatic vinyl-based copolymer resin; approximately 0.01-1 parts by weight of a metal aliphatic sulfonate; and approximately 0.01-2 parts by weight of a fluorinated olefin-based resin, wherein the modified aromatic vinyl-based copolymer resin is a polymer of a monomer mixture comprising an aromatic vinyl-based monomer and glycidyl (meth)acrylate. The thermoplastic resin composition has excellent flame retardancy, transparency and the like.

Abstract: The present disclosure relates to a novel piperidine-2,6-dione derivative and a use thereof and, more specifically, to a piperidine-2,6-dione derivative compound having a structure of a thalidomide analog. A compound of chemical formula 1 according to the present disclosure specifically binds with CRBN protein, and is involved in functions thereof. Therefore, the compound of the present disclosure can be favorably used in the prevention or treatment of leprosy, chronic graft versus host disease, an inflammatory disease, or cancer, which are caused by actions of CRBN protein.

Abstract: A thermoplastic resin composition of the present invention comprises: approximately 100 parts by weight of a polycarbonate resin; approximately 0.01-2 parts by weight of a modified aromatic vinyl-based copolymer resin; approximately 0.01-1 parts by weight of a metal aliphatic sulfonate; and approximately 0.01-2 parts by weight of a fluorinated olefin-based resin, wherein the modified aromatic vinyl-based copolymer resin is a polymer of a monomer mixture comprising an aromatic vinyl-based monomer and glycidyl (meth)acrylate. The thermoplastic resin composition has excellent flame retardancy, transparency and the like.

Abstract: A thermoplastic resin composition of the present invention contains: a polycarbonate resin; a siloxane copolymer comprising a repeat unit represented by chemical formula 1 and a repeat unit represented by chemical formula 2; a metal aromatic sulfonate; a fluorinated olefin-based resin; and an inorganic filler having a difference in refractive index with the polycarbonate resin of approximately 0-0.01. The thermoplastic resin composition has excellent flame retardancy, transparency, stiffness, heat resistance, balance of these physical properties, and the like.

Abstract: The present disclosure relates to a novel piperidine-2,6-dione derivative and a use thereof and, more specifically, to a piperidine-2,6-dione derivative compound having a structure of a thalidomide analog. A compound of chemical formula 1 according to the present disclosure specifically binds with CRBN protein, and is involved in functions thereof. Therefore, the compound of the present disclosure can be favorably used in the prevention or treatment of leprosy, chronic graft versus host disease, an inflammatory disease, or cancer, which are caused by actions of CRBN protein.

Abstract: A thermoplastic resin composition of the present invention contains: a polycarbonate resin; a siloxane copolymer comprising a repeat unit represented by chemical formula 1 and a repeat unit represented by chemical formula 2; a metal aromatic sulfonate; a fluorinated olefin-based resin; and an inorganic filler having a difference in refractive index with the polycarbonate resin of approximately 0-0.01. The thermoplastic resin composition has excellent flame retardancy, transparency, stiffness, heat resistance, balance of these physical properties, and the like.

Abstract: Disclosed are novel indanone derivatives, pharmaceutically acceptable salts thereof or enantiomers, a preparation method thereof, and a pharmaceutical composition for the prevention or treatment of viral diseases, comprising the same as an active ingredient. The indanone derivatives have excellent inhibitory activity against picornaviruses including coxsackie-, entero-, echo-, Polio-, and rhinoviruses, as well as exhibiting low cytotoxicity, so that they can be useful as an active ingredient of a pharmaceutical composition for the prevention or treatment of viral diseases including poliomyelitis, paralysis, acute hemorrhagic conjunctivitis, viral meningitis, hand-foot-and-mouth disease, vesicular disease, hepatitis A, myositis, myocarditis, pancreatitis, diabetes, epidemic myalgia, encephalitis, cold, herpangina, foot-and-mouth disease, asthma, chronic obstructive pulmonary disease, pneumonia, sinusitis or otitis media.

Abstract: A thermoplastic resin composition of the present invention comprises: about 100 parts by weight of a polycarbonate resin; about 10 to about 140 parts by weight of a (meth)acrylic-based resin which comprises a repeating unit represented by chemical formula 1; about 10 to about 80 parts by weight of an aromatic phosphate ester-based compound; and about 10 to 110 parts by weight of a glass fiber, wherein the difference in refractive index between the glass fiber and a resin mixture comprising the polycarbonate resin, the (meth)acrylic-based resin, and the aromatic phosphate ester-based compound is about 0.02 or less. The thermoplastic resin composition has excellent transparency and mechanical strength such as impact resistance, flexural modulus, etc.

Abstract: Disclosed are novel indanone derivatives, pharmaceutically acceptable salts thereof or enantiomers, a preparation method thereof, and a pharmaceutical composition for the prevention or treatment of viral diseases, comprising the same as an active ingredient. The indanone derivatives have excellent inhibitory activity against picornaviruses including coxsackie-, entero-, echo-, Polio-, and rhinoviruses, as well as exhibiting low cytotoxicity, so that they can be useful as an active ingredient of a pharmaceutical composition for the prevention or treatment of viral diseases including poliomyelitis, paralysis, acute hemorrhagic conjunctivitis, viral meningitis, hand-foot-and-mouth disease, vesicular disease, hepatitis A, myositis, myocarditis, pancreatitis, diabetes, epidemic myalgia, encephalitis, cold, herpangina, foot-and-mouth disease, asthma, chronic obstructive pulmonary disease, pneumonia, sinusitis or otitis media.

Abstract: Disclosed are indanone derivatives, pharmaceutically acceptable salts thereof or enantiomers, a preparation method thereof, and a pharmaceutical composition for the prevention or treatment of viral diseases, comprising the same as an active ingredient. The indanone derivatives have excellent inhibitory activity against picornaviruses including coxsackie-, entero-, echo-, Polio-, and rhinoviruses, as well as exhibiting low cytotoxicity, so that they can be useful as an active ingredient of a pharmaceutical composition for the prevention or treatment of viral diseases including poliomyelitis, paralysis, acute hemorrhagic conjunctivitis, viral meningitis, hand-foot-and-mouth disease, vesicular disease, hepatitis A, myositis, myocarditis, pancreatitis, diabetes, epidemic myalgia, encephalitis, cold, herpangina, foot-and-mouth disease, asthma, chronic obstructive pulmonary disease, pneumonia, sinusitis or otitis media.